A clue to the therapy of neurofibromatosis type 2: NF2/Merlin is a PAK1 inhibitor

Yumiko Hirokawa; Anjali Tikoo; John Huynh; Tamara Utermark; C. Oliver Hanemann; Marco Giovannini; Guang Hui Xiao; Joseph R. Testa; John Wood; Hiroshi Maruta

doi:10.1097/00130404-200401000-00006

A clue to the therapy of neurofibromatosis type 2: NF2/Merlin is a PAK1 inhibitor

Yumiko Hirokawa
, Anjali Tikoo
, John Huynh
, Tamara Utermark
, C. Oliver Hanemann
, Marco Giovannini
, Guang Hui Xiao
, Joseph R. Testa
, John Wood
, Hiroshi Maruta^*

^*Corresponding author for this work

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	20-26
Number of pages	6
Journal	CANCER JOURNAL
Volume	10
Issue number	1
DOIs	https://doi.org/10.1097/00130404-200401000-00006
Publication status	Published - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00130404-200401000-00006

Cite this

@article{b966e6b92f4e41f2b8c8205603eed528,

title = "A clue to the therapy of neurofibromatosis type 2: NF2/Merlin is a PAK1 inhibitor",

author = "Yumiko Hirokawa and Anjali Tikoo and John Huynh and Tamara Utermark and Hanemann, \{C. Oliver\} and Marco Giovannini and Xiao, \{Guang Hui\} and Testa, \{Joseph R.\} and John Wood and Hiroshi Maruta",

year = "2004",

doi = "10.1097/00130404-200401000-00006",

language = "English",

volume = "10",

pages = "20--26",

journal = "CANCER JOURNAL",

issn = "1528-9117",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - A clue to the therapy of neurofibromatosis type 2: NF2/Merlin is a PAK1 inhibitor

AU - Hirokawa, Yumiko

AU - Tikoo, Anjali

AU - Huynh, John

AU - Utermark, Tamara

AU - Hanemann, C. Oliver

AU - Giovannini, Marco

AU - Xiao, Guang Hui

AU - Testa, Joseph R.

AU - Wood, John

AU - Maruta, Hiroshi

PY - 2004

Y1 - 2004

U2 - 10.1097/00130404-200401000-00006

DO - 10.1097/00130404-200401000-00006

M3 - Article

SN - 1528-9117

VL - 10

SP - 20

EP - 26

JO - CANCER JOURNAL

JF - CANCER JOURNAL

IS - 1

ER -